F. Bach
Oncoscience (Germany)(DE)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Neuroblastoma Research and Treatments, Cancer, Hypoxia, and Metabolism, Brain Metastases and Treatment, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma(2015)199 cited
- → Experimental Chemotherapy of Tuberculosis. II. The Synthesis of Pyrazinamides and Related Compounds1(1952)145 cited
- → Results of nimotuzumab and vinorelbine, radiation and re-irradiation for diffuse pontine glioma in childhood(2014)98 cited
- → Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial(2013)78 cited
- → Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer(2010)67 cited
- → Nimotuzumab treatment of malignant gliomas(2012)62 cited
- → Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study(2019)46 cited
- → Final report of a phase II trial of nimotuzumab in the treatment of refractory and relapsed high-grade gliomas in children and adolescents(2007)34 cited
- → A comparative study of freezing single cells and spheroids: Towards a new model system for optimizing freezing protocols for cryobanking of human tumours(2008)33 cited
- → Final results of a randomized phase III trial of nimotuzumab for the treatment of newly diagnosed glioblastoma in addition to standard radiation and chemotherapy with temozolomide versus standard radiation and temoziolamide.(2012)24 cited